Retinal vein occlusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Between 40 and 70 years old; 2. It conforms to the Western medicine diagnostic criteria of non-ischemic branch retinal vein occlusion and conforms to the TCM syndrome differentiation criteria of phlegm and blood stasis. The course of the disease is more than 2 weeks; 3. OCT examination showed macular edema, and the thickness of the central retina was more than 250µm; 4. Agree to participate in this clinical trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. There is severe turbidity of the refractive medium; 2. Those with loss of central vision in the late course of the disease; 3. Combined with other macular diseases of the retina; 4. Persons who are allergic or possibly allergic to drugs; 5. Patients suffering from severe cardiovascular and cerebrovascular diseases or severely impaired liver and kidney function and systemic failure, or combined with severe global diseases, cannot tolerate relevant eye examinations and surgical treatment; 6. Women during pregnancy and lactation; 7. Patients who are participating in clinical trials of other drugs or who have used similar Chinese medicines and other treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vision-related quality of life in patients with macular edema secondary to branch retinal vein occlusion Questionnaire (The BRVO ME on Quality of Life (BMIQ) Questionnaire);Recurrence time of macular edem;The number of anti-VEGF drugs injected by the patient;OCT measures macular edema;Patient's blood lipids (total cholesterol, triglycerides, high-density lipoprotein, low-density fat);FA detection of blood vessels in fundus;TCM syndrome score; | — |
Countries
China
Contacts
Eye Hospital, China Academy of Chinese Medical Sciences